Steward Partners Investment Advisory, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,180
-81.9%
1,0000.0%0.00%
Q4 2022$12,030
+100.5%
1,0000.0%0.00%
Q3 2022$6,000
-33.3%
1,000
-50.0%
0.00%
Q2 2022$9,000
-47.1%
2,0000.0%0.00%
Q1 2022$17,000
-41.4%
2,0000.0%0.00%
Q4 2021$29,000
-47.3%
2,000
-20.0%
0.00%
-100.0%
Q3 2021$55,000
+175.0%
2,500
+66.7%
0.00%
Q2 2021$20,000
-100.0%
1,500
-98.8%
0.00%
-100.0%
Q1 2021$1,249,680,000
+20827900.0%
123,000
+8100.0%
0.01%
Q4 2020$6,000
+50.0%
1,500
+50.0%
0.00%
Q2 2020$4,000
+33.3%
1,0000.0%0.00%
Q1 2020$3,000
-40.0%
1,0000.0%0.00%
Q4 2019$5,000
+66.7%
1,0000.0%0.00%
Q3 2019$3,0000.0%1,0000.0%0.00%
Q2 2019$3,000
+200.0%
1,000
+233.3%
0.00%
Q3 2018$1,000
-50.0%
3000.0%0.00%
Q2 2018$2,000
+100.0%
3000.0%0.00%
Q1 2018$1,000
-50.0%
3000.0%0.00%
Q4 2017$2,0003000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders